1-methyl-3-isobutylxanthine has been researched along with Bladder Cancer in 2 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hahn, GL | 1 |
| Haynes, L | 1 |
| Chlapowski, FJ | 1 |
| Boyer, B | 1 |
| Thiery, JP | 1 |
2 other studies available for 1-methyl-3-isobutylxanthine and Bladder Cancer
| Article | Year |
|---|---|
Variations of adenosine 3',5'-cyclic monophosphate levels in four chemically transformed rat transitional epithelial cell lines.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine Monophosphate; Animals; Cell Line; Cell Transformation, Neopl | 1980 |
Cyclic AMP distinguishes between two functions of acidic FGF in a rat bladder carcinoma cell line.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Benzylidene Compounds; | 1993 |